ArticleCancer gene therapy2016

Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy.

S L Hulin-Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.